China Pharma Holdings (CPHI) Price to FCF (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Price to FCF came in at 814.69 in Q2 2026, down 3928.16% on a YoY basis from 21.28 in Q2 2025, and down 188.44% quarter-over-quarter from 282.45 in Q1 2026.
Powered by 
Analysis
China Pharma Holdings (CPHI) Price to FCF (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has reported Price to FCF for 17 consecutive years, with 814.69 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to FCF fell 3928.16% year-over-year to 814.69; the trailing twelve-month figure through Jun 2026 stood at 188.93 (down 1342.09% YoY), and the FY2025 full-year result was 58.39, up 739.13% from the prior year.
- Price to FCF slipped to 814.69 in Q2 2026 per CPHI's latest filing, from 282.45 in the prior quarter.
- Across five years, Price to FCF topped out at 34.27 in Q4 2025 and bottomed at 814.69 in Q2 2026.
- Historically, Price to FCF has averaged 90.5 across 5 years, with a median of 21.09 in 2022.
- The sharpest annual moves came in 2024 and 2025: Price to FCF slumped 5474.07% in 2024, then soared 136.29% in 2025.
- Over 5 years, Price to FCF stood at 8.24 in 2022, then slumped by 1025.33% to 76.24 in 2023, then jumped by 119.07% to 14.54 in 2024, then soared by 135.65% to 34.27 in 2025, then slumped by 2477.49% to 814.69 in 2026.
- According to Business Quant data, Price to FCF over the past three periods registered 814.69, 282.45, and 34.27 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -814.69 |
| Mar 31, 2026 | -282.45 |
| Dec 31, 2025 | 34.27 |
| Sep 30, 2025 | -36.86 |
| Jun 30, 2025 | 21.28 |
| Mar 31, 2025 | -65.02 |
| Dec 31, 2024 | 14.54 |
| Sep 30, 2024 | -111.85 |
| Jun 30, 2024 | -58.64 |
| Mar 31, 2024 | -9.40 |
| Dec 31, 2023 | -76.24 |
| Sep 30, 2023 | 2.08 |
| Jun 30, 2023 | -13.60 |
| Mar 31, 2023 | -2.33 |
| Dec 31, 2022 | 8.24 |
| Sep 30, 2022 | -196.20 |
| Jun 30, 2022 | -20.78 |
| Mar 31, 2022 | -21.39 |
| Dec 31, 2021 | -111.35 |
| Sep 30, 2021 | -30.50 |